HomeVirtual CatalogLearningSpecial EventsConnection Café & ExhibitsGeneral InfoTravel & HotelExhibitors

Courses by Topic

• Anatomic Pathology
• Clinical Pathology
• Practice Management
• Special Topics
• SAM Courses

---

Courses by Day

• Sunday
• Monday
• Tuesday
• Wednesday

---

Faculty Index

• A - G
• H - P
• Q - Z

Home | Learning | Courses by Topic – Anatomic Pathology | AP111  Myeloid Neoplasms: Morphology to Molecular Genetics

NEW  AP111  Myeloid Neoplasms: Morphology to Molecular Genetics

8:00–11:30 am
3.0 CME CREDITS

The diagnosis of acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and myeloproliferative neoplasms has evolved from a morphologic evaluation to incorporating immunophenotyping, cytogenetics, and molecular genetic studies. This course will summarize the 2008 World Health Organization classification of myeloid neoplasms and will describe a systematic method for using morphology with ancillary studies to classify and determine prognosis in AML, MDS, and myeloproliferative neoplasms. You will learn when to order specific studies using an algorithmic approach and how to incorporate the findings into a comprehensive report. Faculty also will address coming advances in the diagnosis and prognosis of myeloid neoplasms so that you are aware of future testing for these diseases.

You will learn to:

• Correctly classify cases of acute myeloid leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms
• Order necessary ancillary tests to classify and determine prognosis in acute myeloid leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms
• Incorporate ancillary testing to compose a comprehensive report that represents the final diagnosis for acute myeloid leukemia, myelodysplastic syndrome, and myeloproliferative neoplasms
• Describe new advances in the diagnosis and prognosis of myeloid neoplasms

Faculty
Daniel A. Arber, MD
Tracy I. George, MD, FCAP